NSMCE2, a Novel Super-Enhancer Regulated Gene, is Linked to Poor Prognosis and Therapy Resistance in Breast Cancer
C. Di Benedetto, J. Oh, Z. Choidhery, W. Shi, G. Valdes, P. Betancur
This study identifies NSMCE2 as a super-enhancer regulated gene linked to poor prognosis and therapy resistance in breast cancer, showing that targeting it can enhance chemotherapy effectiveness.
bioRxiv · Apr 1, 2022Cancer Biology